Related Experiment Video
Updated: Mar 1, 2026

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
Increase in vasopressin binding sites in the human choroid plexus in Alzheimer's disease
C Korting1, E J van Zwieten, G J Boer
1Graduate School Neurosciences Amsterdam, Netherlands Institute for Brain Research.
Abstract:
Vasopressin binding sites were determined in the choroid plexus of five Alzheimer's disease patients and five non-demented controls using the 125I-labelled linear V1a-antagonist. The Alzheimer's disease patients showed a twofold increase in the density of vasopressin binding sites, whereas the increase in the affinity constant Kd did not reach significance.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Neuron Structure
Structure and Function of Neurons
The neuronal cell body—the soma— houses the nucleus and organelles vital to...
Ligand-Gated Ion Channel Receptor: Gating Mechanism

